47 results on '"Sparling, David"'
Search Results
2. Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry
3. Greening Manufacturing Supply Chains – Introducing Bio-based Products into Manufacturing Supply Chains
4. A Framework for Translating Biotechnology Experiences to Nanotechnology
5. 111-OR: MODY3 Diagnosis from Deidentified Pancreatic Tissue Leads to Variant Identification in Living Relatives
6. Inhibition of γ-secretase in adipocytes leads to altered IL-6 secretion and adipose inflammation
7. Weight Loss Results in Increased Expression of Anti‐Inflammatory Protein CRISPLD2 in Mouse Adipose Tissue
8. Strategic Alliances in the Canadian Biotechnology Sector
9. Macrophage‐Derived microRNA‐155 Increases in Obesity and Influences Adipocyte Metabolism by Targeting Peroxisome Proliferator‐Activated Receptor Gamma
10. 1277-P: Diabetes Management Supplies in Youth with Type 1 Diabetes: Don’t Leave Home Without Them!
11. Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study
12. Adipocyte Gamma-Secretase Inhibition May Alter IL-6 Expression and Trafficking
13. Adipocyte-specific blockade of gamma-secretase, but not inhibition of Notch activity, reduces adipose insulin sensitivity
14. mTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2
15. Congenital hypothyroidism and thyroid dyshormonogenesis: a case report of siblings with a newly identified mutation in thyroperoxidase
16. Farm Support Payments and Risk Balancing: Implications for Financial Riskiness of Canadian Farms
17. Innovation and commercialisation in the Canadian bioproducts industry
18. Regulation and the financial performance of Canadian agribusinesses
19. GLUT4 Enhancer Factor (GEF) Interacts with MEF2A and HDAC5 to Regulate the GLUT4 Promoter in Adipocytes
20. Firm, market, and regulatory factors influencing innovation and commercialization in Canada's functional food and nutraceutical sector
21. Hyperphosphorylation of MEF2A in primary adipocytes correlates with downregulation of human GLUT4 gene promoter activity
22. Factors affecting biotechnology innovation in Canada: analysis of the 2001 biotechnology use and development survey
23. Risking Market Integration without Regulatory Integration: The Case of NAFTA and BSE
24. Exercise increases MEF2‐ and GEF DNA‐binding activities in human skeletal muscle
25. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase
26. Further thoughts on the relationship between economic value added and stock market performance
27. An assessment of the strategies and strengths of medium‐sized food processors
28. Simulations and supply chains: strategies for teaching supply chain management
29. Novel Role for an HPt Domain in Stabilizing the Phosphorylated State of a Response Regulator Domain
30. Rol-Land Farms-Passing the Mantle
31. The relationship between economic value added and the stock market performance of agribusiness firms
32. Degradation of the Nuclear Matrix Is a Common Element during Radiation-Induced Apoptosis and Necrosis
33. The Impact of Bank Mergers on Canadian Farm and Rural Communities
34. Reinsuring Agricultural Risk
35. Supply Chain Management and the Canadian Agri‐food Sector
36. Balancing Just-In-Time Production Units: TheNU-Line Balancing Problem
37. Managing and reducing total cycle time: models and analysis
38. Responsibility for child health care
39. Letters to the Editor
40. Who Delivers Higher Quality Care?
41. Consent
42. The Hidden Cost Dilemma
43. Pediatrics and Record-keeping
44. On Alternative Approaches to Immunizing Children
45. AAP Code of Ethics for the Use of Fetuses and Fetal Material for Research
46. A Comment on ???Peer Review in Ambulatory Care???
47. The Task Force Replies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.